Laboratory testing for plasma homocysteine (HCY) levels can enhance the risk assessment of several diseases, including cardiovascular diseases.1 Elevated homocysteine levels have been considered to be independent risk factors for a variety of cardiovascular conditions and diseases including atherosclerosis and thrombosis, stroke, and peripheral vascular disease.1-6
Reliable Answers to Critical Cardiac Questions
As a recognized leader in CVD testing, Siemens Healthcare Diagnostics offers multiple instrument choices for homocysteine testing, which allows for earlier identification of high-risk populations for cardiovascular diseases, facilitating initiation of quicker preventive and therapeutic measures.
Homocysteine assays are available on the following systems from Siemens Healthcare Diagnostics:
- ADVIA Centaur® System
- ADVIA Centaur® XP Immunoassay System
- ADVIA Centaur® CP Immunoassay System
- IMMULITE® 1000 Immunoassay System
- IMMULITE® 2000 / IMMULITE® 2000 XPi Immunoassay System
- American Heart Association. What is Homocysteine?
http://www.americanheart.org/presenter.jhtml?identifier=535. Accessed December 2008.
- Stanger O, et al. Clin Chem Lab Med. 2003;41:1392-403.
- Stanger O, et al. Z Kardiol. 2004;93(6):439-53.
- Maron BA, et al. Annu Rev Med. 2008. [Epub ahead of print].
- van Meurs JB, et al. N Engl J Med. 2004;350:2033-41.
- American Heart Association. Homocysteine, Folic Acid and Cardiovascular Disease.
http://www.americanheart.org/presenter.jhtml?identifier=4677. Accessed December 2008.